Acknowledgements

Excerpt

The Editors-in-Chief thank the following ad hoc reviewers and our Editorial Board for evaluating manuscripts submitted to Cancer Immunology, Immunotherapy in 2017. We are committed to the publication of research that advances the field of tumor immunology and immunotherapy and rely on our many reviewers to ensure that papers accepted by the journal adhere to all aspects of good scientific and ethical practice and have significant scientific merit. We very much appreciate the voluntary unremunerated provision of their expertise and time by our reviewers, and recognize that their constructive comments and recommendations are essential contributions promoting the overall quality of Cancer Immunology, Immunotherapy and the scientific record. …